BCAB Annual Cash & Cash Equivalents
$111.47 M
-$104.04 M-48.27%
31 December 2023
Summary:
As of January 23, 2025, BCAB annual cash & cash equivalents is $111.47 million, with the most recent change of -$104.04 million (-48.27%) on December 31, 2023. During the last 3 years, it has fallen by -$127.13 million (-53.28%). BCAB annual cash & cash equivalents is now -54.50% below its all-time high of $244.98 million, reached on December 31, 2021.BCAB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAB Quarterly Cash And Cash Equivalents
$56.52 M
-$5.15 M-8.35%
30 September 2024
Summary:
As of January 23, 2025, BCAB quarterly cash and cash equivalents is $56.52 million, with the most recent change of -$5.15 million (-8.35%) on September 30, 2024. Over the past year, it has dropped by -$5.15 million (-8.35%). BCAB quarterly cash and cash equivalents is now -79.06% below its all-time high of $269.93 million, reached on September 30, 2021.BCAB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BCAB Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.3% | -8.3% |
| 3 y3 years | -53.3% | -72.1% |
| 5 y5 years | +926.1% | -74.5% |
BCAB Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.5% | at low | -76.9% | at low |
| 5 y | 5-year | -54.5% | +2909.5% | -79.1% | +1425.8% |
| alltime | all time | -54.5% | +2909.5% | -79.1% | +1425.8% |
BioAtla Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $56.52 M(-8.3%) |
| June 2024 | - | $61.66 M(-23.5%) |
| Mar 2024 | - | $80.63 M(-27.7%) |
| Dec 2023 | $111.47 M(-48.3%) | $111.47 M(-21.1%) |
| Sept 2023 | - | $141.28 M(-16.2%) |
| June 2023 | - | $168.69 M(-12.5%) |
| Mar 2023 | - | $192.69 M(-10.6%) |
| Dec 2022 | $215.51 M | $215.51 M(+21.0%) |
| Sept 2022 | - | $178.12 M(-11.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $202.29 M(-7.8%) |
| Mar 2022 | - | $219.43 M(-10.4%) |
| Dec 2021 | $244.98 M(+2.7%) | $244.98 M(-9.2%) |
| Sept 2021 | - | $269.93 M(+30.0%) |
| June 2021 | - | $207.61 M(-6.1%) |
| Mar 2021 | - | $221.20 M(-7.3%) |
| Dec 2020 | $238.60 M(+6341.8%) | $238.60 M(+320.4%) |
| Sept 2020 | - | $56.76 M(+1432.3%) |
| Dec 2019 | $3.70 M(-65.9%) | $3.70 M |
| Dec 2018 | $10.86 M | - |
FAQ
- What is BioAtla annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BioAtla?
- What is BioAtla annual cash & cash equivalents year-on-year change?
- What is BioAtla quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BioAtla?
- What is BioAtla quarterly cash and cash equivalents year-on-year change?
What is BioAtla annual cash & cash equivalents?
The current annual cash & cash equivalents of BCAB is $111.47 M
What is the all time high annual cash & cash equivalents for BioAtla?
BioAtla all-time high annual cash & cash equivalents is $244.98 M
What is BioAtla annual cash & cash equivalents year-on-year change?
Over the past year, BCAB annual cash & cash equivalents has changed by -$104.04 M (-48.27%)
What is BioAtla quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BCAB is $56.52 M
What is the all time high quarterly cash and cash equivalents for BioAtla?
BioAtla all-time high quarterly cash and cash equivalents is $269.93 M
What is BioAtla quarterly cash and cash equivalents year-on-year change?
Over the past year, BCAB quarterly cash and cash equivalents has changed by -$5.15 M (-8.35%)